Literature DB >> 8635922

Functional status instruments: outcome measure in the evaluation of patients with chronic obstructive pulmonary disease.

S C Lareau1, E H Breslin, P M Meek.   

Abstract

The purpose of this article is to review the instruments developed to measure functional status in patients with chronic obstructive pulmonary disease. Because the ability to carry out day-to-day activities is of primary importance to patients with chronic obstructive pulmonary disease, it is necessary for clinicians to understand which instruments provide the best measures of patient activity levels. Furthermore, as a critical outcome in managed care services, pulmonary critical pathways, and patient disability, the measurement of functional status in clinical practice assumes greater relevance. Functional status instruments in this review will refer to questionnaires measuring the day-to-day activities of patients. Questionnaires reviewed will include those that provide measures of general health status with activity-specific items, as well as questionnaires specifically designed to evaluate patients with pulmonary disease. The psychometric strengths, reliability and validity, and clinical utility of the instruments will be presented.

Entities:  

Mesh:

Year:  1996        PMID: 8635922     DOI: 10.1016/s0147-9563(96)80032-x

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  12 in total

1.  Measuring Quality of Live in Disorders of Sleep and Breathing.

Authors:  Marlene Reimer; W. Ward Flemons
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

2.  Outcome Measures in Cardiopulmonary Physical Therapy: Focus on the Glittre ADL-Test for People with Chronic Obstructive Pulmonary Disease.

Authors:  Gail Dechman; Susan A Scherer
Journal:  Cardiopulm Phys Ther J       Date:  2008-12

Review 3.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

4.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

5.  Two Behavioral Interventions for Patients with Major Depression and Severe COPD.

Authors:  George S Alexopoulos; Jo Anne Sirey; Samprit Banerjee; Dimitris N Kiosses; Cristina Pollari; Richard S Novitch; Amanda Artis; Patrick J Raue
Journal:  Am J Geriatr Psychiatry       Date:  2016-07-20       Impact factor: 4.105

6.  Outcome measurement for COPD: reliability and validity of the Dyspnea Management Questionnaire.

Authors:  Anna Norweg; Alan M Jette; Pengsheng Ni; Jonathan Whiteson; Minjin Kim
Journal:  Respir Med       Date:  2010-09-29       Impact factor: 3.415

7.  Putting health status guided COPD management to the test: protocol of the MARCH study.

Authors:  Janwillem Kocks; Corina de Jong; Marjolein Y Berger; Huib A M Kerstjens; Thys van der Molen
Journal:  BMC Pulm Med       Date:  2013-07-04       Impact factor: 3.317

8.  Effects of the six-minute walking test on dyspnea and activities of daily living in pneumoconiosis patients.

Authors:  Eun-Jin Kim; Hye-Soon Kim; Myung-Hee Lee
Journal:  J Exerc Rehabil       Date:  2014-10-31

9.  Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease.

Authors:  T Perez; B Arnould; J-M Grosbois; V Bosch; I Guillemin; M-L Bravo; M Brun; A-B Tonnel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

10.  Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.

Authors:  Katsura Nagai; Hironi Makita; Masaru Suzuki; Kaoruko Shimizu; Satoshi Konno; Yoichi M Ito; Masaharu Nishimura
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.